Imaging & mpMRI Archives - Page 14 of 17 - Sperling Prostate Center

3 Areas in which mpMRI Wins 1st Prize After Prostate Cancer Treatment

Prostate MRI vs Biopsy - Sperling Prostate Center

No one can dispute the superiority of multiparametric MRI (mpMRI) over transrectal ultrasound (TRUS) for detecting and characterizing prostate cancer (PCa) before biopsy and treatment. The past five years alone have seen a rapid accumulation of research evidence that mpMRI makes it possible to save medical dollars by avoiding unnecessary biopsies and their risks. While keep reading

How Much Can You Know About Your Prostate Cancer Before Treatment?

MRI prostate cancer treatment - Sperling Prostate Center

Prostate cancer is a complex disease, and understanding the full extent of it is crucial before making treatment decisions. Multiparametric MRI (mpMRI) offers a detailed view of your prostate, helping to identify critical information to guide your treatment plan. keep reading

PI-RADS Updates Improve Prostate Imaging, Interpretation and Reporting

Prostate Cancer Screening - Sperling Prostate Center

A new PI-RADS version improves earlier guidelines for more consistent image acquisition, interpretation, scoring and reporting... keep reading

Molecules, Math and MRI

Miomolecular MRI Imaging - Sperling Prostate Center

The renowned British poet Elizabeth Barrett Browning composed one of the most famous love sonnets of all times: How do I love thee? Let me count the ways. It is a declaration of the love she had for her husband, Robert Barrett. Had she been a 21st century radiologist with an equal gift for words, keep reading

Artificial Intelligence: Enlarging the Mind of Radiology

Artificial Intelligence and Radiology - Sperling Prostate Center

The late physicist Stephen Hawking was one of the most brilliant minds of his time. He believed that Artificial Intelligence (AI) could serve the good of the world. He also got the world’s attention when he warned about the danger that AI could eventually outsmart humanity. He urged that its creators exercise responsibility with best keep reading

Shocking Study! Obesity Lowers Death Risk in Certain PCa Cases

At first, the headline is surprising, evening shocking: “Obesity Linked to Lower Death Risk in Non-metastatic CRPC[i] (castration resistant prostate cancer).” Does this news report mean that for men with advanced (but not metastatic) prostate cancer that no longer responds to hormones, being fat extends life? This does not seem to make sense. A decade keep reading

What is the PI-RADS Score?

The tremendous international interest in 3T multiparametric MRI (mpMRI) brought with it the challenge of how to standardize the reporting of prostate image analysis among radiologists around the globe. The European Society of Urogenital Radiology (ESUR) proposed a numeric system called the Prostate Imaging Reporting and Data System, or PI-RADS, for prostate cancer detection. It keep reading

Multiparametric MRI Predicts Recurrence After Prostatectomy

Let’s pretend that you are a prostate cancer patient whose doctor, a well-known robotic surgeon, recommends robotic-assisted radical prostatectomy (RRP). He makes some very persuasive points: Based on the Partin tables you have less than a 12% chance of biochemical recurrence (rising PSA) in three years after treatment. He’ll “get it all out” and you keep reading

Multiparametric MRI Before Prostate Biopsy: Dawn of a New Era

“Change is inevitable. Progress is optional.” Tony Robbins In medicine, change sometimes happens with two steps forward but one step back. For example, in the early 20th century, delivering babies in hospitals became more popular than home births in order to have “painless” births with anesthesia. However, for many women the higher complication and infection keep reading

Less Expensive MRI Rules Out Unnecessary Prostate Biopsy

Two problems face men who have a high PSA or abnormal digital rectal exam (DRE). First, they are often referred for a conventional TRUS needle biopsy of the prostate because there is suspicion of prostate cancer (PCa). Second, multiparametric MRI is considered too time-consuming and expensive for routine determination of the need for a biopsy. keep reading

Category: Imaging & mpMRI